MARCHETTI, Antonio
 Distribuzione geografica
Continente #
EU - Europa 1.014
NA - Nord America 103
AS - Asia 47
AF - Africa 3
SA - Sud America 2
Totale 1.169
Nazione #
FR - Francia 804
IT - Italia 137
US - Stati Uniti d'America 101
IE - Irlanda 23
SE - Svezia 18
VN - Vietnam 12
JP - Giappone 9
IN - India 6
ES - Italia 5
GB - Regno Unito 5
CH - Svizzera 4
NL - Olanda 4
SA - Arabia Saudita 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
TR - Turchia 3
BG - Bulgaria 2
BR - Brasile 2
CA - Canada 2
PH - Filippine 2
RO - Romania 2
RU - Federazione Russa 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
DE - Germania 1
DK - Danimarca 1
FI - Finlandia 1
IR - Iran 1
KR - Corea 1
MA - Marocco 1
MY - Malesia 1
RS - Serbia 1
SG - Singapore 1
TH - Thailandia 1
Totale 1.169
Città #
Paris 146
Chieti 66
Dublin 23
Ashburn 18
Stockholm 18
Dong Ket 11
Rome 11
Boston 10
Varallo 7
Bend 6
Boardman 6
Milan 5
Cankaya 3
Council Bluffs 3
Glasgow 3
Hartford 3
Messina 3
Málaga 3
Niigata 3
Amsterdam 2
Bezons 2
Bologna 2
Colle di Val d'Elsa 2
East Falmouth 2
Houston 2
Las Palmas de Gran Canaria 2
Lausanne 2
Louisville 2
Napoli 2
New Taipei 2
Padova 2
Pune 2
Saint-Basile-le-Grand 2
San Francisco 2
San Mateo 2
Ta'if 2
Takajomachi 2
Tappahannock 2
Terlizzi 2
Trieste 2
Wilmington 2
Yokohama 2
Andover 1
Ann Arbor 1
Aquila 1
Bacoli 1
Bangkok 1
Belgrade 1
Bengaluru 1
Brunico 1
Bucharest 1
Cambridge 1
Campi Bisenzio 1
Central 1
Cheyenne 1
Chuocho 1
Dubai 1
Flushing 1
Fontebuona 1
Hanoi 1
Helsinki 1
Hillsboro 1
Hyderabad 1
Jeddah 1
Karasawa 1
Kolkata 1
Kuala Lumpur 1
Lafayette 1
Lanciano 1
Laurel 1
Naga 1
Poulsbo 1
Redmond 1
Royal Tunbridge Wells 1
Salé 1
San Diego 1
San Jose 1
Seattle 1
Sofia 1
Spoltore 1
Tampines New Town 1
Tehran 1
Valduggia 1
Varna 1
Vienna 1
Wanchai 1
Worcester 1
Totale 439
Nome #
Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients, file e4233f18-8511-2860-e053-6605fe0a460a 777
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm, file e4233f16-3c70-2860-e053-6605fe0a460a 93
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe, file e4233f17-7659-2860-e053-6605fe0a460a 61
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations., file e4233f14-f5b4-2860-e053-6605fe0a460a 41
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives, file e4233f17-7ea4-2860-e053-6605fe0a460a 29
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays, file e4233f19-62ab-2860-e053-6605fe0a460a 17
A multidisciplinary group for prostate cancer management: A single institution experience, file e4233f16-84b9-2860-e053-6605fe0a460a 16
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies, file e4233f17-7a4b-2860-e053-6605fe0a460a 14
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations, file e4233f19-164e-2860-e053-6605fe0a460a 12
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment, file e4233f17-11cb-2860-e053-6605fe0a460a 11
Real-world data on NGS diagnostics: A survey from the Italian Society of Pathology (SIAPeC) NGS Network, file e4233f19-4dcd-2860-e053-6605fe0a460a 11
POLE exonuclease domain mutations in endometrial carcinoma: a case report, file 65ee5822-d67b-4832-a947-82619f8c1ce2 10
null, file e4233f17-851a-2860-e053-6605fe0a460a 10
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice, file e4233f17-7878-2860-e053-6605fe0a460a 9
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors, file e4233f19-2967-2860-e053-6605fe0a460a 9
Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project, file e4233f19-6530-2860-e053-6605fe0a460a 8
BRCA1/2 molecular assay for ovarian cancer patients: A survey through Italian departments of oncology and molecular and genomic diagnostic laboratories, file e4233f19-4f8a-2860-e053-6605fe0a460a 7
ROS1 Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm, file e4233f16-f5dc-2860-e053-6605fe0a460a 5
Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project, file e4233f17-763c-2860-e053-6605fe0a460a 5
Digital pathology and PD-L1 testing in non small cell lung cancer: A workshop record, file e4233f19-4f89-2860-e053-6605fe0a460a 5
p95HER2 Truncated Form in Resected Non-small Cell Lung Cancer., file e4233f14-f5b6-2860-e053-6605fe0a460a 4
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing., file e4233f15-0812-2860-e053-6605fe0a460a 4
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors., file e4233f17-858d-2860-e053-6605fe0a460a 3
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments, file e4233f18-ebd9-2860-e053-6605fe0a460a 3
2nd ESMO Consensus Conference in Lung Cancer: Locally advanced stage III non-small-cell lung cancer, file e4233f17-788b-2860-e053-6605fe0a460a 2
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays, file e4233f19-7854-2860-e053-6605fe0a460a 2
AKT1(E17K) in human solid tumours, file e4233f14-f033-2860-e053-6605fe0a460a 1
HIGH-RISK HUMAN PAPILLOMA VIRUS INFECTION, TUMOR PATHOPHENOTYPES AND BRCA1/2 AND P53 STATUS IN JUVENILE BREAST CANCER PATIENTS., file e4233f14-f1c3-2860-e053-6605fe0a460a 1
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series., file e4233f15-6ddd-2860-e053-6605fe0a460a 1
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients, file e4233f19-26b3-2860-e053-6605fe0a460a 1
Totale 1.172
Categoria #
all - tutte 2.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 1 0 0
2019/202017 2 0 0 0 0 0 0 0 0 11 4 0
2020/202149 1 0 0 0 2 4 2 3 12 4 7 14
2021/202295 4 4 5 4 7 5 2 4 2 4 19 35
2022/2023160 4 2 2 0 3 15 19 13 26 24 35 17
2023/2024848 6 1 2 6 6 475 258 6 79 9 0 0
Totale 1.172